Cyclobenzaprine for Postoperative Pain in Minimally Invasive Hysterectomy

ConditionsMinimally Invasive Surgical Procedures Abnormal Uterine Bleeding, Unspecified Adenomyosis of Uterus Fibroid Uterus Chronic Pelvic Pain Endometriosis Menorrhagia Endometritis Adnexal Diseases

Trial statusNot yet recruiting

Trial phasePhase 4

Trial typeInterventional

Biological sexFemale

Age18+

SponsorChristiana Care Health Services

About this trial

Typical postoperative pain control after minimally invasive hysterectomy includes ibuprofen, acetaminophen, and a short course of narcotics. The purpose of this study is to see if adding cyclobenzaprine to this regime improves pain control and lessens narcotic use.

Eligibility criteria

Qualifiers

Age >18yo

Female

English speaking

Undergoing (robotic assisted or classic) total laparoscopic hysterectomy ± unilateral or bilateral salpingectomy ± unilateral or bilateral oophorectomy

Disqualifiers

Age <18yo

Male

Pregnant, breastfeeding

Non-English speaking

Trial design

Treatments tested in this trial

Cyclobenzaprine

Treatment groups

36 Participants

are divided into 2 treatment groups

Sponsors and collaborators

Christiana Care Health Services

Lead sponsor

Source ClinicalTrials.gov